Evidence map›Paper›PMID 30524061›Full record

ArticlePhysics in medicine and biology2018

Design and testing of a microcontroller that enables alpha particle irradiators to deliver complex dose rate patterns.

Tomer Nawrocki, Thomas C Tritt, Prasad V S V Neti, Alex S Rosen, Akhil R Dondapati, Roger W Howell

Open access · greenAbstract read
In one paragraph

Article in Physics in medicine and biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. MIRD Pamphlet No. 31: MIRDcell V4-Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tomer NawrockiDivision of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States of America.
Thomas C TrittDivision of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States of America.
Prasad V S V NetiDivision of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States of America.
Alex S RosenDivision of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States of America.
Akhil R DondapatiDivision of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States of America.
Roger W HowellDivision of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States of America.ORCID 0000-0002-7057-8110
Rutgers, The State University of New Jersey · US

Funding

PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA019536 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI MAHON, GWENDOLYN MARIA, WHITEHEAD, IAN P · 1985 to 2014
$2.8M
Radiation induced bystander effects in radium-223 therapyR01CA198073 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI AZZAM, EDOUARD I, HOWELL, ROGER W. · 2015 to 2018
$1.3M
NCI NIH HHS R01 CA198073NCI NIH HHS R25 CA019536
6 · The paper itself

Abstract

There is increasing interest in using alpha particle emitting radionuclides for cancer therapy because of their unique cytotoxic properties which are advantageous for eradicating tumor cells. The high linear energy transfer (LET) of alpha particles produces a correspondingly high density of ionizations along their track. Alpha particle emitting radiopharmaceuticals deposit this energy in tissues over prolonged periods with complex dose rate patterns that depend on the physical half-life of the radionuclide, and the biological uptake and clearance half-times in tumor and normal tissues. We have previously shown that the dose rate increase half-time that arises as a consequence of these biokinetics can have a profound effect on the radiotoxicity of low-LET radiation. The microcontroller hardware and software described here offer a unique way to deliver these complex dose rate patterns with a broad-beam alpha particle irradiator, thereby enabling experiments to study the radiobiology of complex dose rate patterns of alpha particles. Complex dose rate patterns were created by precise manipulation of the timing of opening and closing of the electromechanical shutters of an α-particle irradiator. An Arduino Uno and custom circuitry was implemented to control the shutters. The software that controls the circuits and shutters has a user-friendly Graphic User Interface (GUI). Alpha particle detectors were used to validate the programmed dose rate profiles. Circuit diagrams and downloadable software are provided to facilitate adoption of this technology by other radiobiology laboratories.

Indexed as

Linear Energy TransferRadiopharmaceuticalsSoftwareAlpha ParticlesHalf-LifeHumansNeoplasmsRadiobiologyRadiopharmaceuticals

Identifiers

PMID30524061
PMCPMC8528213
OpenAlexW2901792376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.